63539-189 : Ibrance 125 mg Oral Capsule
NDC: | 63539-189 |
Labeler: | U.S. Pharmaceuticals |
Product Type: | Human Prescription Drug |
Drug Name: | Ibrance |
Dosage Form: | Oral Capsule |
Application #: | NDA207103 |
Rev. Date: |
Appearance:
Markings: | PBC;125;Pfizer |
Shapes: |
Capsule |
Colors: |
Brown |
Size (mm): | 22 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
NDC Package Codes:
- 63539-189-11: 21 CAPSULE IN 1 BOTTLE (63539‑189‑11)
Active Ingredients:
- Palbociclib
Dosage Strength:
- 125 mg
Inactive Ingredients:
- Cellulose, Microcrystalline
- Lactose Monohydrate
- Sodium Starch Glycolate Type a Potato
- Silicon Dioxide
- Magnesium Stearate
- Gelatin
- Ferric Oxide Red
- Ferric Oxide Yellow
- Titanium Dioxide
- Shellac
- Ammonia
- Propylene Glycol
- Dimethicone
Pharmaceutical Classes:
- Kinase Inhibitor [EPC]
- Kinase Inhibitors [MoA]
- Cytochrome P450 3A Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 63539-187 Ibrance 75 mg Oral Capsule by U.S. Pharmaceuticals
- 63539-188 Ibrance 100 mg Oral Capsule by U.S. Pharmaceuticals
- 63539-284 Ibrance 75 mg Oral Tablet, Film Coated by Us Pharmaceuticals
- 63539-486 Ibrance 100 mg Oral Tablet, Film Coated by Us Pharmaceuticals
- 63539-688 Ibrance 125 mg Oral Tablet, Film Coated by Us Pharmaceuticals
- 0069-0187 Ibrance 75 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
- 0069-0188 Ibrance 100 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
- 0069-0189 Ibrance 125 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
- 0069-0284 Ibrance 75 mg Oral Tablet, Film Coated by Pfizer Laboratories Div Pfizer Inc
- 0069-0486 Ibrance 100 mg Oral Tablet, Film Coated by Pfizer Laboratories Div Pfizer Inc
- 0069-0688 Ibrance 125 mg Oral Tablet, Film Coated by Pfizer Laboratories Div Pfizer Inc
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 63539-188Next: 63539-193 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.